NCT00996151已完成1 期
A Healthy Volunteer, Single Dose Phase I Trial to Determine the Amount of Testerone MD-Lotion 2% Remaining on the Axilla After Washing.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- The amount of Testerone MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure.
研究概览
简要总结
The study will evaluate the amount of Testosteron MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy male subjects ≥18 and ≤ 70 years
排除标准
- •Disqualifying concurrent condition or allergy/sensitivity to Testosterone MD-Lotion
结局指标
主要结局
The amount of Testerone MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure.
时间窗: March 2010
次要结局
- The safety and tolerability of Testosterone MD-Lotion 2% following a single dose application. This will be performed by review of adverse events, EKG and assessment of laboratory parameters (haematology, biochemistry, urinalysis and hormone levels).(March 2010)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A Study of Axiron® in Healthy ParticipantsHealthy VolunteersNCT02004132Eli Lilly and Company12
已完成
2 期
Study of 3 Doses of ARD-0403 in Testosterone Deficient MenHypogonadismNCT00597051Ardana Bioscience Ltd42
已完成
1 期
An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male SubjectsHealthy SubjectsNCT02116907Eisai Inc.7
尚未招募
2 期
Product Transference Study of Testagen™ TDS®-TestosteroneHypogonadotropismNCT02733133Transdermal Delivery Solutions Corp96
已完成
3 期
Study of Transdermal Testosterone Patches in Menopausal Women With Low LibidoHypoactive Sexual Desire DisorderNCT00131495Warner Chilcott814